e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function
A. Martin, N. Soler, J. Montserrat, E. Ballester, E. Gobartt, M. Miravitlles, A. Torres (Madrid, Barcelona, Spain)
Source:
Annual Congress 2005 - COPD - treatment III
Session:
COPD - treatment III
Session type:
Thematic Poster Session
Number:
1956
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Martin, N. Soler, J. Montserrat, E. Ballester, E. Gobartt, M. Miravitlles, A. Torres (Madrid, Barcelona, Spain). Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function. Eur Respir J 2005; 26: Suppl. 49, 1956
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Maintenance of benefits following an out-patient pulmonary rehabilitation program in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Benefits of pulmonary rehabilitation program in patients with persistent asthma
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
Efficacy of comprehensive education program including inhaler training and disease management on COPD
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
GENebu Project: home nebulizer use and maintenance in Italy
Source: Eur Respir J 2001; 18: 758-763
Year: 2001
Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Impact of a educational program in the use of inhalers in patients derived to a respiratory rehabilitation unit
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Improving asthma care with use of asthma action plan and inhaler technique check in a children‘s hospital
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Influence of pulmonary rehabilitation in patients with COPD on use of primary and secondary care resources
Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation
Year: 2003
Is it feasible for respiratory physiologists to carry out inhaler device technique checks during routine pulmonary function tests?
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Effects of a home-based early pulmonary rehabilitation program on health resources use after a severe exacerbation of COPD
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
Integrated care prevents hospitalisations for exacerbations in COPD patients
Source: Eur Respir J 2006; 28: 123-130
Year: 2006
Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept